Phase II study shows combination improves survival of metastatic melanoma patients

ew blood vessels from forming and allows the chemotherapy to work.

Fifty-three patients were treated with carboplatin, weekly treatments of paclitaxel (Taxol) and biweekly bevacizumab. Researchers found that the treatment was well tolerated and prevented the tumor from spreading from eight to nearly 24 weeks.

The number of new melanoma cases has continued to rise at a rate of about 5 percent to 10 percent each year since the 1970s, Dr. Markovic says. Why" One cause, he says, is depletion of the ozone layer, but also, more cases are coming to light due to greater public awareness.

"The increase in incidence is a big worry, particularly when we still do not have an effective treatment. That's why this step, however small, is important," Dr. Markovic says.


Contact: Amy Reyes
Mayo Clinic

Page: 1 2 3

Related medicine news :

1. GSK announces launch of largest ever Phase III trial in lung cancer treatment
2. MacroChem completes patient enrollment for Phase II trial of EcoNail for treatment of onychomycosis
3. Drug combination proves effective against myeloma in Phase I trial
4. Researchers present Phase 2 clinical results for Acologix AC-100
5. Positive results for ACRUXs lead product in US Phase 3 trial
6. Ebola DNA vaccine produces immune responses in all fully vaccinated volunteers in Phase 1 trial
7. GroPep starts Phase 1 infertility trial
8. Bayer launches Phase III clinical study of Trasylol in elective spinal fusion surgery
9. Joint statement on Savvy Phase 3 trial in Ghana to test the effectiveness of Savvy Gel in preventing HIV
10. NIAID launches first Phase II trial of a global HIV/AIDS vaccine
11. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals

Post Your Comments:
(Date:10/10/2015)... MI (PRWEB) , ... October 10, 2015 , ... Isabel ... MO. , On the heels of the release of the Institute of Medicine’s ... tools, and their integration with Cerner solutions that assist healthcare providers and consumers to ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... ... for highly sought after internships at the pre-eminent organization in global health: the ... to eliminating social and health disparities. These internships are a mechanism for WHO ...
(Date:10/9/2015)... ... October 09, 2015 , ... Smoke alarms can save lives. In fact, according ... of dying in reported home fires in half. As part of Fire Prevention Week, ... property installed and maintained. , Half of home fire deaths result from fires reported ...
(Date:10/9/2015)... ... October 09, 2015 , ... On Saturday, September 26, 2015, 48-year-old MS ... in Madrid, Spain. Representing both the USA and Sweden in the Speed and Power ... Am Front Crosses, she was awarded 1 Silver and 4 Gold Medals. , “I ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... ... States, is welcoming individuals from all walks of life to save money on ... set price of $25 per month per medication, individuals and families can receive ...
Breaking Medicine News(10 mins):
(Date:10/9/2015)... October 9, 2015 --> ... has announced its execution of an Intellectual Property & Subsidiary ... Cannabics, Inc. a Delaware Corporation, related party, and a ... --> --> These agreements were ... Company, whereby the Research and Development components shall now ...
(Date:10/9/2015)...  The Centers for Disease Control and Prevention, ... Infectious Diseases, Office of Advanced Molecular Detection (OAMD), ... collaboration to evaluate the performance of Edico Genome,s ... collaboration is to evaluate the utility of the ... infectious disease applications. This collaboration will also focus ...
(Date:10/9/2015)... , Oct. 9, 2015   Lexicon Pharmaceuticals, Inc. ... the TELESTAR Phase 3 clinical study of telotristat etiprate has ... Society annual symposium to be held from October 15-17, in ... interviews with patients who completed the randomized treatment portion of ... in a poster session. --> ...
Breaking Medicine Technology:
Cached News: